-
1.
公开(公告)号:US07803783B2
公开(公告)日:2010-09-28
申请号:US11707386
申请日:2007-02-16
申请人: Mark Lee , Calvin Jay Kuo , Tannishtha Reya , Irving L. Weissman
发明人: Mark Lee , Calvin Jay Kuo , Tannishtha Reya , Irving L. Weissman
IPC分类号: A61K31/713
CPC分类号: A61K38/17 , C07K2319/30
摘要: Methods and compositions are provided for the protection of normal cells from cytoreductive therapy that target proliferating cells, by administering an inhibitor of Wnt signaling pathways. Wnt signaling is critically important for homeostasis of the epithelial lining of the adult intestine and other proliferating normal adult tissues.
摘要翻译: 提供了通过施用Wnt信号通路抑制剂来保护正常细胞免受靶向增殖细胞的细胞减灭治疗的方法和组合物。 Wnt信号对成年肠和其他增殖正常成人组织的上皮内皮的稳态至关重要。
-
2.
公开(公告)号:US09464275B2
公开(公告)日:2016-10-11
申请号:US12545755
申请日:2009-08-21
申请人: Calvin Jay Kuo , Akifumi Ootani
发明人: Calvin Jay Kuo , Akifumi Ootani
CPC分类号: C12N5/0679 , C12N5/0012 , C12N2501/415 , C12N2533/54 , G01N33/5005 , G01N33/5073
摘要: Methods are provided for long term culture of mammalian intestinal cells. Cultures are initiated with fragments of mammalian intestinal tissue, which are then maintained embedded in a gel substrate that provides an air-liquid interface. Intestinal epithelium in cultures of the invention can be continuously grown for extended periods of time. Mammalian intestinal cells cultured by the methods of the invention recapitulate features of intestinal growth in vivo.
摘要翻译: 为哺乳动物肠细胞的长期培养提供方法。 培养物由哺乳动物肠组织的片段引发,然后将其保持嵌入提供空气 - 液体界面的凝胶基质中。 本发明培养物中的肠上皮可以连续生长较长时间。 通过本发明的方法培养的哺乳动物肠细胞重现肠内生长的特征。
-
公开(公告)号:US20100278810A1
公开(公告)日:2010-11-04
申请号:US12600984
申请日:2008-05-23
申请人: Frank Kuhnert , Hsiao-Ting Wang , Calvin Jay Kuo
发明人: Frank Kuhnert , Hsiao-Ting Wang , Calvin Jay Kuo
IPC分类号: A61K39/395 , A61K31/711 , A61K31/7105 , A61K31/713 , A61P25/00 , A61P9/10 , A61P3/10 , A61P35/00
CPC分类号: G01N33/74 , G01N33/574 , G01N2333/515 , G01N2333/726 , G01N2500/04 , G01N2800/16 , G01N2800/347
摘要: The present invention provides methods of modulating angiogenesis in an individual, the methods generally involving administering to an individual an agent that modulates the expression or activity of GPR124. In one embodiment, the methods of the invention relate to inhibiting pathological angiogenesis by decreasing activity of GPR124, which method may be carried out in conjunction with administration of one or more other anti-angiogenic agents.
摘要翻译: 本发明提供调节个体血管发生的方法,所述方法通常涉及向个体施用调节GPR124的表达或活性的药剂。 在一个实施方案中,本发明的方法涉及通过降低GPR124的活性来抑制病理性血管生成,该方法可以与一种或多种其它抗血管生成剂的给药一起进行。
-
公开(公告)号:US20080113911A1
公开(公告)日:2008-05-15
申请号:US11879655
申请日:2007-07-17
申请人: Calvin Jay Kuo , Frank Kuhnert
发明人: Calvin Jay Kuo , Frank Kuhnert
IPC分类号: A61K38/18
CPC分类号: A61K38/1709
摘要: The present invention provides methods of modulating angiogenesis in an individual, the methods generally involving administering to an individual an agent that modulates the expression or activity of Egfl7, where an agonist of Egfl7, including an Egfl7 polypeptide, decreases angiogenesis. In one embodiment, the methods of the invention relate to inhibiting pathological angiogenesis by enhancing activity of Egfl7, which method may be carried out in conjunction with administration of one or more other anti-angiogenic agents.
摘要翻译: 本发明提供调节个体血管发生的方法,所述方法通常涉及向个体施用调节Egfl7的表达或活性的试剂,其中Egfl7的激动剂(包括Egfl7多肽)降低血管发生。 在一个实施方案中,本发明的方法涉及通过增强Egfl7的活性来抑制病理性血管发生,该方法可以与一种或多种其它抗血管生成剂的给药一起进行。
-
公开(公告)号:US07947278B2
公开(公告)日:2011-05-24
申请号:US11879655
申请日:2007-07-17
申请人: Calvin Jay Kuo , Frank Kuhnert
发明人: Calvin Jay Kuo , Frank Kuhnert
CPC分类号: A61K38/1709
摘要: The present invention provides methods of modulating angiogenesis in an individual, the methods generally involving administering to an individual an agent that modulates the expression or activity of Egfl7, where an agonist of Egfl7, including an Egfl7 polypeptide, decreases angiogenesis. In one embodiment, the methods of the invention relate to inhibiting pathological angiogenesis by enhancing activity of Egfl7, which method may be carried out in conjunction with administration of one or more other anti-angiogenic agents.
摘要翻译: 本发明提供调节个体血管发生的方法,所述方法通常涉及向个体施用调节Egfl7的表达或活性的试剂,其中Egfl7的激动剂(包括Egfl7多肽)降低血管发生。 在一个实施方案中,本发明的方法涉及通过增强Egfl7的活性来抑制病理性血管生成,该方法可以与一种或多种其它抗血管生成剂的给药一起进行。
-
6.
公开(公告)号:US20100047853A1
公开(公告)日:2010-02-25
申请号:US12545755
申请日:2009-08-21
申请人: Calvin Jay Kuo , Akifumi Ootani
发明人: Calvin Jay Kuo , Akifumi Ootani
CPC分类号: C12N5/0679 , C12N5/0012 , C12N2501/415 , C12N2533/54 , G01N33/5005 , G01N33/5073
摘要: Methods are provided for long term culture of mammalian intestinal cells. Cultures are initiated with fragments of mammalian intestinal tissue, which are then maintained embedded in a gel substrate that provides an air-liquid interface. Intestinal epithelium in cultures of the invention can be continuously grown for extended periods of time. Mammalian intestinal cells cultured by the methods of the invention recapitulate features of intestinal growth in vivo.
摘要翻译: 为哺乳动物肠细胞的长期培养提供方法。 培养物由哺乳动物肠组织的片段引发,然后将其保持嵌入提供空气 - 液体界面的凝胶基质中。 本发明培养物中的肠上皮可以连续生长较长时间。 通过本发明的方法培养的哺乳动物肠细胞重现肠内生长的特征。
-
-
-
-
-